Lead StorySynergy!: In October the pharmaceutical division of Japan Tobacco, the world’s third-largest cigarette company, bought the rights to lung-cancer vaccines now under development by the U.S. firms Cell Genesys and Corixa. Now under one roof are the cause, treatment and potential prevention of lung cancer. The Continuing Crisis The…